The end of a subsidy program that helped keep costs down for Medicare drug coverage could leave millions of seniors with higher monthly costs, a move that undermines the Trump administration’s message of cutting drug costs. President Trump often touts his push for access to cheaper drugs through the TrumpRx platform and making “most-favored-nation” deals…
